Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood Pressure

• Publication date

  2006-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/08037050601037760PMID 17380848
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of cancer and the oral contraceptive pill

  2007cited by this paper
• Může závažná esenciální hypertenze způsobit vzestup BNP vedoucí k falešné diagnóze srdečního selhání

  2006cited by this paper
• Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

  2005cited by this paper
• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

  2005cited by this paper
• Bedside tests of B‐type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients

  2005cited by this paper
• Can natriuretic peptides be used for the diagnosis of diastolic heart failure?

  2004cited by this paper
• N‐terminal pro brain natriuretic peptide in arterial hypertension—a marker for left ventricular dimensions and prognosis

  2004cited by this paper
• Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism.

  2004cited by this paper
• Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region

  2003cited by this paper
• B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients.

  2003cited by this paper
• Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.

  2002cited by this paper
• Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction.

  2001cited by this paper
• Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP

  2000cited by this paper
• Primary aldosteronism.

  1998cited by this paper
• Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease.

  1998cited by this paper
• Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure

  1998cited by this paper
• Plasma brain natriuretic peptide during ergometric exercise in hypertensive patients with left ventricular hypertrophy.

  1996cited by this paper
• Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

  1996cited by this paper
• Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.

  1996cited by this paper
• Exercise-induced secretion of brain natriuretic peptide in essential hypertension and normal subjects.

  1995cited by this paper
• Brain natriuretic peptide is synthesized in the human adrenal medulla and its messenger ribonucleic acid expression along with that of atrial natriuretic peptide are enhanced in patients with primary aldosteronism.

  1994cited by this paper
• Principles and Practice of Echocardiography

  1994cited by this paper
• Plasma brain natriuretic peptide and C‐type natriuretic peptide in essential hypertension

  1994cited by this paper
• Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension.

  1993cited by this paper
• Brain natriuretic peptide as a cardiac hormone in essential hypertension.

  1992cited by this paper
• Reassessment of the predictive value of the postural stimulation test in primary aldosteronism.

  1991cited by this paper
• Detection of Left Ventricular Hypertrophy by M‐Mode Echocardiography: Anatomic Validation, Standardization, and Comparison to Other Methods

  1987cited by this paper
• Electron Spin Resonance Studies of Erythrocytes from Spontaneously Hypertensive Rats and Humans with Essential Hypertension

  1987cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978influential reference
• Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy.

  1976cited by this paper
• Saline suppression of plasma aldosterone in hypertension.

  1971cited by this paper
• [Primary aldosteronism].

  1969cited by this paper

• Machine learning-based prediction of primary aldosteronism subtype using comprehensive clinical features.

  2026cites this paper
• Natriuretic peptides and cardiac troponins in hypertension and heart failure: A contemporary review of the evidence.

  2026cites this paper
• Subclinical Primary Aldosteronism is Characterized by Maladaptive Natriuretic Peptide and Adrenal Hormonal Physiology.

  2025cites this paper
• NT-pro-BNP Level is Related to Left Ventricular Remodeling in Patients With Primary Aldosteronism

  2024cites this paper
• Impact of medical checkup parameters on major adverse cardiovascular events in the general Japanese population

  2024cites this paper
• Plasma B-type natriuretic peptide level as a possible predictor of dietary salt intake

  2022cites this paper
• Diurnal blood pressure pattern and cardiac damage in hypertensive patients with primary aldosteronism

  2021cites this paper
• NT-proBNP and metabolic risk factors in a bi-ethnic cohort: the Ambulatory Blood Pressure in African prospective cohort study.

  2020cites this paper
• Central blood pressure reflects left ventricular load, while brachial blood pressure reflects arterial damage

  2014cites this paper
• B‐type natriuretic peptide in hypertensive crises: Diagnostic use in hypertensive urgencies and emergencies

  2013cites this paper
• Association of Plasma B-Type Natriuretic Peptide Concentrations With Longitudinal Blood Pressure Tracking in African Americans: Findings From the Jackson Heart Study

  2013influential citation
• Left ventricle remodeling in men with moderate to severe volume-dependent hypertension

  2012cites this paper
• B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent’s Screening TO Prevent Heart Failure) study

  2011cites this paper
• Natriuretic peptides in the regulation of the hypothalamic-pituitary-adrenal axis.

  2010cites this paper
• Plasma brain natriuretic peptide: a biochemical marker of effective blood pressure management?

  2009cites this paper
• Natriuretic peptides - physiology, pathophysiology and clinical use in heart failure.

  2009cites this paper
• Peptidi natriuretici cardiaci: gli ormoni del cuore

  2008cites this paper
• Brain natriuretic peptide, systolic and diastolic blood pressures.

  2008cites this paper
• Does B-Type Natriuretic Peptide Predict the New Onset of Hypertension?

  2008cites this paper